IPO Outlook For The Week: Banks And Biotechs

For a more comprehensive IPO calendar, check out the offering in Benzinga Cloud. The IPO dates below are expected but not confirmed.

ADC Therapeutics SA ADCT will issue nearly 8.2 million shares between $23 and $26 Thursday on the New York Stock Exchange. The offering represents 11.1% of outstanding shares and is expected to raise about $244.1 million. The clinical-stage biotech company develops therapies for solid tumors and hematological cancers.

Aprea Therapeutics, Inc. APRE will issue 5 million shares between $14 and $16 Thursday on the Nasdaq. The offering represents 26% of outstanding shares and is expected to raise about $92 million. With operations in Boston and Sweden, the biopharmaceutical company develops protein therapies for acute myeloid leukemia, myelodysplastic syndromes and other oncological indications.

Frequency Therapeutics, Inc. FREQ will issue 6.7 million shares between $14 and $16 Thursday on the Nasdaq. The offering represents 21.5% of outstanding shares and is expected to raise about $123.3 million. The clinical-stage company produces therapies for degenerative diseases like multiple sclerosis and sensorineural hearing loss.

Metrocity Bankshares, Inc. will issue more than 1.9 million shares between $14.50 and $16.50 Thursday on the Nasdaq. The offering represents 7.7% of outstanding shares and is expected to raise about $36.8 million. Headquartered in Georgia, the financial services company supports personal and business banking through 10 locations in Georgia, Alabama and Florida.

Viela Bio, Inc. VIE will issue 7.5 million shares between $19 and $21 Thursday on the Nasdaq. The offering represents 15.2% of outstanding shares and is expected to raise about $181.1 million. The Maryland biotech company develops therapies for autoimmune and inflammatory diseases.

Related Links:

What Is Reg A+?

What Is A Lock-Up Expiration Date And Why Is It Important?